Cargando…
Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study
The COVID-19 pandemic has posed challenges to maintaining medical care for patients with Parkinson’s disease (PD). The Parkinson’s Disease during the COVID-19 Pandemic (ParCoPa) survey was conducted as an online, nationwide, cross-sectional survey from December 2020 to March 2021 and aimed to assess...
Autores principales: | Wolff, Andreas Wolfgang, Haller, Bernhard, Demleitner, Antonia Franziska, Westenberg, Erica, Lingor, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946104/ https://www.ncbi.nlm.nih.gov/pubmed/35326309 http://dx.doi.org/10.3390/brainsci12030353 |
Ejemplares similares
-
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives
por: Wolff, Andreas Wolfgang, et al.
Publicado: (2023) -
Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic
por: Demleitner, Antonia F., et al.
Publicado: (2022) -
Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023) -
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
por: Lingor, Paul, et al.
Publicado: (2022) -
Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan
por: Ikenberg, Benno, et al.
Publicado: (2021)